Impact of primary tumor sidedness on erlotinib efficacy in patients with metastatic colorectal cancer treated with bevacizumab maintenance: Results from the DREAM phase III trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of primary tumor sidedness on erlotinib efficacy in patients with metastatic colorectal cancer treated with bevacizumab maintenance: Results from the DREAM phase III trial.
Type de publicationJournal Article
Year of Publication2018
AuteursChibaudel B, Andre T, Samson B, Garcia-Larnicol M-L, Dauba J, Lledo G, Dupuis OJean Marie, Rinaldi Y, Mabro M, Aucoin N, Viret F, Tubiana-Mathieu N, Khalil A, Hamed GNabil Baba, Scheithauer W, Carola E, Vernerey D, Louvet C, de Gramont A, Tournigand C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.4_suppl.737